Zota Health Care Limited

NSE ZOTA.NS

Zota Health Care Limited EBT Margin for the year ending March 31, 2024: -8.96%

Zota Health Care Limited EBT Margin is -8.96% for the year ending March 31, 2024, a -167.18% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Zota Health Care Limited EBT Margin for the year ending March 31, 2023 was -3.35%, a -135.36% change year over year.
Zota Health Care Limited EBT Margin for the year ending March 31, 2022 was 9.48%, a 2,870.04% change year over year.
Zota Health Care Limited EBT Margin for the year ending March 31, 2021 was -0.34%, a -108.43% change year over year.
Zota Health Care Limited EBT Margin for the year ending March 31, 2020 was 4.06%, a -55.74% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

NSE: ZOTA.NS

Zota Health Care Limited

CEO	Dr. Sujit Paul
IPO Date	May 10, 2017
Location	India
Headquarters	Zota House
Employees	445
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.

Key trends

Past 5 years